Predictive Oncology Stock Income Statements

Predictive Oncology Quarterly Income Statements Chart

Quarterly

Annual

Revenue

Gross Profit

Operating Profit

Net Income

Predictive Oncology Quarterly Income Statements Table

Quarterly

Annual

Unit: USD	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2010-12-31	2010-03-31	2009-12-31	2009-06-30
revenue	335,032	715,056	490,110	239,895	363,473	455,827	371,591	314,568	476,493	313,663	350,207	280,317	293,788	480,757	182,784	294,943	347,477	522,696	286,151	255,241	311,547	329,930	358,586	411,593	220,313	152,535	106,822	175,166	139,564	134,605	85,422	96,905	183,276	85,792	234,012	151,274	165,792	397,254	318,293	70,220	81,707	107,835	150,856	127,727	89,562	51,615	24,960	22,635	73,999	20,264	2,374	-4,613	288	-19,154	15,737
cost of revenue	406,296	106,940	159,761	120,139	153,438	108,151	134,075	109,443	136,224	110,165	142,877	97,758	94,068	175,206	85,261	92,657	131,608	208,096	118,390	73,717	106,444	83,006	108,970	117,343	60,336	28,706	22,010	36,992	32,490	26,481	36,766	85,883	104,675	19,773	83,566	95,968	121,149	134,726	98,365	31,083	54,587	26,181	67,335	41,604	43,062	69,962	1,710	13,806	43,099	11,161	1,820	140	140	-450	7,450
gross profit	-71,264	608,116	330,349	119,756	210,035	347,676	237,516	205,125	340,269	203,498	207,330	182,559	199,720	305,551	97,523	202,286	215,869	314,600	167,761	181,524	205,103	246,924	249,616	294,250	159,977	123,829	84,812	138,174	107,074	108,124	48,656	11,022	78,601	66,019	150,446	55,306	44,643	262,528	219,928	39,137	27,120	81,654	83,521	86,123	46,500	-18,347	23,250	8,829	30,900	9,103	554	-4,753	148	-18,704	8,287
operating expenses
research and development	99,462	20,671	29,367	38,805	203,557	15,151	33,393	0	0	0	0	0	713,074	568,766	521,116	548,753	514,893	707,414	1,271,258	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
sales and marketing	375,478	336,043	429,103	370,237	450,040	333,377	271,022	304,467	327,232	172,869	159,788	114,641	65,999	121,514	133,015	264,409	238,699	434,955	685,029	554,216	643,065	621,465	554,084	550,538	323,779	301,672	231,270	147,454	119,122	137,784	102,616	108,448	64,286	66,720	139,026	233,957	328,941	325,141	319,303	204,920	221,519	164,712	108,593	83,969	98,398	13,508	29,164	31,900	83,469	60,989	68,534	22,528	73,052	62,378	105,624
general and administrative
total operating expenses	1,804,411	2,583,574	2,704,527	2,335,984	3,047,470	3,287,918	2,351,696	2,423,651	3,521,917	2,061,458	2,077,973	3,270,777	2,085,046	2,226,634	3,211,817	2,828,476	2,355,913	2,616,991	3,310,368	1,497,945	1,918,723	762,603	1,108,434	1,503,734	3,280,716	621,716	2,214,705	1,132,073	490,669	733,074	2,262,481	2,078,943	2,281,075	1,063,897	1,007,532	-106,478	1,868,343	920,673	1,621,806	1,444,555	1,956,779	3,549,616	1,093,061	2,027,549	1,493,124	2,818,833	2,099,537	635,458	2,898,561	428,843	272,870	342,796	712,135	205,214	604,635
operating income	3,434,678	3,762,196	4,126,672	3,584,739	4,638,621	4,478,425	3,531,831	3,619,189	4,756,171	2,883,262	2,805,557	3,960,230	2,864,119	2,916,914	3,865,948	3,641,638	3,109,505	3,759,360	5,266,655	2,518,727	3,032,475	2,108,007	1,662,518	2,054,272	3,029,028	1,115,924	2,628,482	1,480,021	839,846	1,163,714	2,609,937	2,187,391	2,345,361	1,130,617	1,146,558	127,479	2,197,284	1,245,814	1,941,109	1,649,475	2,178,298	3,714,328	1,201,654	2,111,518	1,591,522	2,832,341	2,128,701	667,358	2,579,551	625,190	516,934	-668,278	849,922	363,143	780,872
net income	-3,505,940	-3,154,080	-3,959,228	-3,464,983	-4,428,586	-4,130,749	3,841,524	-3,414,064	-8,559,177	-5,493,556	-2,598,227	-3,777,671	-12,543,897	-5,608,363	-3,768,425	-3,439,352	-2,893,636	-3,444,760	-5,098,894	-2,337,203	-2,827,372	-1,861,083	-1,412,902	-1,760,022	-2,869,051	992,095	-2,543,670	-1,341,847	-732,772	-1,055,590	-2,561,281	-2,176,369	-2,266,760	-1,064,598	-996,112	-72,173	-2,152,641	-983,286	-1,721,181	-1,610,338	2,151,178	-3,632,674	-1,118,133	-2,025,395	-1,545,022	-2,850,688	-2,105,451	-658,529	-2,548,651	-616,087	-516,380	668,278	-849,774	-362,693	-772,585

We provide you with 20 years income statements for Predictive Oncology stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Predictive Oncology stock. Explore the full financial landscape of Predictive Oncology stock with our expertly curated income statements.

The information provided in this report about Predictive Oncology stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.